Skip to content

Publication Topic: Legislation & Policy

Public Comment | Tissue Agnostic Drug Development in Oncology

RFI | Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee

RFI | Enhancing Adoption of Innovative Clinical Trial Approaches

RFI | Scientific Challenges and Opportunities To Advance the Development of Individualized Cellular and Gene Therapies

Proposed Rule | Medical Devices; Laboratory Developed Tests

Proposed Rule | Medicare Program: Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary

Proposed Rule | Medicare Program: Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary

Proposed Rule | Securing Updated and Necessary Statutory Evaluations Timely

Proposed Rule | Medicare Programs: International Pricing Index Model for Medicare Part B Drugs (CMS-5528-ANPRM)

Proposed Rule | Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses